Isoniazid Dosage Prediction Model Development

NCT02747654 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

NAT2 Genotype

Interventions

GENETIC: genotype

Sponsor

Samsung Medical Center